What does a teledermatology platform include?

A focused platform can include patient identity, consent, structured history, image guidance and upload, appointment or asynchronous intake, clinician queues, comparison views, documentation, messaging, escalation, referral, follow-up, notifications, role access, audit, and integration. Clinicians define required evidence and remain responsible for clinical decisions.

Can the software diagnose a skin condition from a photo?

This service does not promise autonomous diagnosis. Image-only assessment can miss context and quality problems. Any decision-support feature needs clinician-defined intended use, representative evaluation, uncertainty, oversight, monitoring, and the appropriate regulatory review. The clinician or care organisation owns diagnosis, treatment, urgency, and patient communication.

How do you handle poor or missing images?

Use clinician-approved capture guidance, required views, device and file checks, visible quality prompts, retake requests, and an exception path. Do not label an image clinically adequate from generic technical checks alone. The reviewing clinician decides whether evidence is sufficient, requests more information, escalates, or changes the consultation mode.

Can teledermatology software integrate with an EHR?

Yes, when the exact EHR, tenant, authorised interface, data contract, environment, and workflow are available for testing. We define identifiers, document and image references, write authority, retries, reconciliation, audit, and downtime behaviour. A vendor name or standard does not guarantee access or compatibility.

What does focused teledermatology development cost?

A first release starts at $35,000 and usually takes 12 to 16 weeks. It covers one patient intake, one clinician queue, image and history records, consent, documentation, escalation, follow-up, role access, monitoring, and handover. EHR writes, video, decision support, multiple markets, or regulated-device work increase scope.

Teledermatology Platform Development

Teledermatology software for one clinician-owned image review workflow.

We build a bounded store-and-forward or video workflow around patient identity, image capture, history, consent, clinician queues, documentation, escalation, and follow-up. Clinicians own clinical criteria, diagnosis, treatment, urgency, and safety; the software preserves evidence, access, audit, and exceptions.

Bring the problem, the current workflow, or the existing code. We reply with a practical next step within one business day.

Evidence and scope

50+

Adjacent telehealth evidence

Clinics onboarded in the first 12 weeks for a nurse-assisted telehealth platform, not teledermatology.

Starts at $35K

Focused first release

One intake path, one clinician queue, documentation, escalation, and follow-up.

12 to 16 weeks

Typical focused timeline

Clinical workflow mapping, prototype, build, privacy and accessibility tests, pilot, and handover.

Evidence · planning contextSee the work

The brief

Start with what is not working.

Good software decisions begin with the constraint, not a list of features or a preferred technology.

Are patient images detached from identity, consent, capture context, clinical history, or the clinician who reviewed them?

Can staff see what happens when image quality is poor, symptoms require urgent care, or a referral cannot be completed?

Plain answer

Teledermatology software supports clinician-led remote skin review through structured history, image capture, consent, queues, documentation, escalation, and follow-up. It does not diagnose or determine treatment by itself. RaftLabs scopes one clinician-owned workflow first, starting at $35,000 over 12 to 16 weeks, with privacy, accessibility, audit, and exception controls.

The image uploaded. The case was not ready for review.

The photo had no capture date, the side of the body was unclear, and the patient history omitted the symptom that changed urgency. A technical quality score could not settle clinical adequacy. The product needed clinician-approved intake, a request for more evidence, and an escalation path that never implied a diagnosis.

Adjacent telehealth evidence

50+
clinics onboarded: Nurse-assisted telehealth, not dermatology

$35K
starting first release: One intake and clinician review path

12-16 weeks
typical focused timeline: Includes a bounded clinical pilot

The nurse-assisted telehealth case demonstrates remote-care workflow delivery and clinic onboarding. It does not prove dermatology capture quality, diagnosis, treatment, clinical efficacy, EHR compatibility, regulatory status, or patient safety. Those remain subject to the client's clinical protocol, evaluation, governance, and approvals.

Build teledermatology when a clinician-owned review path cannot fit the current telehealth product.

Use a supported telehealth or dermatology system when its capture, records, workflow, assurance, and service fit.

A fit

A clinical organisation owns a defined asynchronous or video dermatology pathway, inclusion rules, escalation, and follow-up.

Clinical, privacy, security, accessibility, records, support, and product owners can approve requirements and evidence.

Representative devices, images, histories, poor-quality cases, urgent cases, integrations, and pilot users are available.

Not a fit

The request assumes a photo alone enables autonomous diagnosis, treatment, urgency, or a safety guarantee.

No accountable clinician owns image adequacy, intake criteria, escalation, documentation, follow-up, or pilot acceptance.

A maintained platform already supports the pathway, or required EHR and imaging interfaces cannot be tested.

Choose the care-product boundary before building

Need	Best fit	Primary boundary
General remote appointments and patient communication	Telehealth platform	Scheduling, identity, video or messaging, records, consent, and follow-up
Dermatology-specific image and asynchronous review	Teledermatology workflow	Capture protocol, history, clinician queue, evidence, escalation, and documentation
Store and view diagnostic images across specialties	Medical imaging system	Imaging formats, archive, viewer, worklist, access, and clinical integration
Automated image decision support	Separately governed medical AI scope	Intended use, clinical evaluation, oversight, regulation, monitoring, and change control

Scope

What belongs in one clinician-led review path

01
Patient intake and consent
Capture identity, contact, location, consent version, history fields, symptoms, duration, prior care, allergies or medicines only when required, and a clear route for emergency or excluded cases.
02
Clinician-approved image capture
Guide required views and context, check basic file properties, preserve original and derived files, record device and time, request retakes, and leave clinical adequacy to the reviewer.
03
Review queue and evidence
Route by approved non-diagnostic criteria, show history and image versions together, support comparison and notes, record reviewer identity, preserve uncertainty, and prevent incomplete cases from appearing final.
04
Escalation and follow-up
Support requests for more evidence, mode changes, referral, urgent-care instructions supplied by the clinical owner, patient notifications, acknowledgement, missed follow-up, and support exceptions.
05
Access, records, and operations
Enforce patient and role scope, protect exports, retain audit and consent, integrate only tested interfaces, monitor queues and failures, document downtime, and hand ownership to clinical and support teams.

How it works

From clinical protocol to one reviewed patient case

Phase 1
01
Define pathway and clinical ownership
Choose one intake and review path, users, markets, image and history requirements, consent, urgency and exclusion rules, clinician decisions, escalation, follow-up, owners, risks, and acceptance measures.
Phase 2
02
Prove capture and integration limits
Test devices, lighting and image guidance, patient identity, records, scheduling or EHR interfaces, permissions, retention, accessibility, connectivity, queue volumes, and representative clinical exceptions.
Phase 3
03
Build the bounded review workflow
Implement intake, image and history records, consent, quality prompts, clinician queues, documentation, escalation, notifications, role access, audit, integration, monitoring, and recovery.
Phase 4
04
Pilot clinicians and hand over
Run approved scenarios, test poor images and urgent escalation, reconcile records, review privacy and accessibility evidence, train clinical and support owners, document limits, monitor the pilot, and release.

Risk

What the clinical workflow must settle

Clinical adequacy: The clinical owner defines required images, history, exclusions, escalation, review, documentation, and follow-up. Software checks cannot certify adequacy.
Urgent presentation: Use clinician-approved wording and routing, make emergency limitations visible, monitor delivery, and never let an automated queue replace urgent-care instructions.
Image and record privacy: Minimise collection, encrypt, restrict access, protect exports, define retention and deletion, preserve consent, and review vendors and hosting with client advisers.
Integration failure: Keep durable identifiers, retries, reconciliation, duplicate control, audit, and a clinician-approved downtime path when records or notifications do not arrive.

Scope and price

A focused teledermatology workflow starts at $35,000.

Start with one intake, clinician queue, capture protocol, documentation, escalation, follow-up, role model, and accountable clinical owner.

This page should consolidate into Build Telehealth App because demand is absent and direct teledermatology proof is not published.

Starting investment

Starts at $35,000

A focused release usually takes 12 to 16 weeks. EHR writes, video, several markets, decision support, or regulated-device work increase scope.

Clinical ownership stays explicit

The client and its clinicians own clinical protocol, diagnosis, treatment, urgency, efficacy, safety, and regulatory decisions.

Evidence is not a diagnosis

The product preserves images, history, consent, reviewer, decisions, and exceptions without claiming autonomous clinical judgement.

Related healthcare services

Teledermatology platform questions

: A focused platform can include patient identity, consent, structured history, image guidance and upload, appointment or asynchronous intake, clinician queues, comparison views, documentation, messaging, escalation, referral, follow-up, notifications, role access, audit, and integration. Clinicians define required evidence and remain responsible for clinical decisions.
: This service does not promise autonomous diagnosis. Image-only assessment can miss context and quality problems. Any decision-support feature needs clinician-defined intended use, representative evaluation, uncertainty, oversight, monitoring, and the appropriate regulatory review. The clinician or care organisation owns diagnosis, treatment, urgency, and patient communication.
: Use clinician-approved capture guidance, required views, device and file checks, visible quality prompts, retake requests, and an exception path. Do not label an image clinically adequate from generic technical checks alone. The reviewing clinician decides whether evidence is sufficient, requests more information, escalates, or changes the consultation mode.
: Yes, when the exact EHR, tenant, authorised interface, data contract, environment, and workflow are available for testing. We define identifiers, document and image references, write authority, retries, reconciliation, audit, and downtime behaviour. A vendor name or standard does not guarantee access or compatibility.
: A first release starts at $35,000 and usually takes 12 to 16 weeks. It covers one patient intake, one clinician queue, image and history records, consent, documentation, escalation, follow-up, role access, monitoring, and handover. EHR writes, video, decision support, multiple markets, or regulated-device work increase scope.

Work with us

Bring the clinical pathway, capture protocol, and exception cases.

Share users, markets, intake, image guidance, history, consent, clinical decisions, urgency rules, EHR, retention, accessibility, pilot cohort, and accountable clinical owner.

Scope and cost agreed before work starts. No surprises. No obligation.
Working prototype within 3 weeks of kickoff.
Pay by milestone. You see progress before each invoice.
60-day post-launch warranty. Bug fixes, UI tweaks, and deployment support. No retainer.
All conversations are NDA-protected.